Cargando…

Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression

BACKGROUND: Bufei Yishen formula (BYF) is an effective prescription for the clinical treatment of chronic obstructive pulmonary disease (COPD). However, the molecular mechanism by which it exerts its pharmacological effects remains to be explored. METHODS: The human bronchial cell line BEAS-2B was t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Weimin, Zhang, Shaohong, Cui, Lei, Chen, Yu, Xu, Xingxing, Wu, Longchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094478/ https://www.ncbi.nlm.nih.gov/pubmed/37065635 http://dx.doi.org/10.2147/COPD.S383295

Ejemplares similares

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
por: Li, Jiansheng, et al.
Publicado: (2014)

Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway
por: Li, Min-yan, et al.
Publicado: (2022)

Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling
por: Xu, Kexin, et al.
Publicado: (2023)

Identification of Metabolites and Metabolic Pathways Related to Treatment with Bufei Yishen Formula in a Rat COPD Model Using HPLC Q-TOF/MS
por: Yang, Liping, et al.
Publicado: (2015)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling
por: Li, Jiansheng, et al.
Publicado: (2016)

Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway
por: Ma, Jindi, et al.
Publicado: (2022)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS
por: Wu, Jinyan, et al.
Publicado: (2022)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease
por: Zhao, Peng, et al.
Publicado: (2018)

Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats
por: Tian, Yange, et al.
Publicado: (2016)

Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-κB Signaling
por: Jin, Fanli, et al.
Publicado: (2022)

Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling
por: Ma, Jindi, et al.
Publicado: (2019)

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats
por: Lu, Xiaofan, et al.
Publicado: (2016)

Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway
por: Tian, Yange, et al.
Publicado: (2017)

Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD
por: Zhao, Peng, et al.
Publicado: (2016)

Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD
por: Zhao, Peng, et al.
Publicado: (2015)

Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence
por: Zhang, Qiaoying, et al.
Publicado: (2022)

Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD
por: Zhao, Peng, et al.
Publicado: (2017)

The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically
por: Yu, Zhibin, et al.
Publicado: (2020)

Repair mechanism of Yishen Tongluo formula on mouse sperm DNA fragmentation caused by polystyrene microplastics
por: Zhang, Chenming, et al.
Publicado: (2023)

COL4A3 expression in asthmatic epithelium depends on intronic methylation and ZNF263 binding
por: Nemani, Sai Sneha Priya, et al.
Publicado: (2021)

A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia
por: Chen, Yangdi, et al.
Publicado: (2021)

Klotho inhibits neuronal senescence in human brain organoids
por: Shaker, Mohammed R., et al.
Publicado: (2021)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021)

A zinc finger family protein, ZNF263, promotes hepatocellular carcinoma resistance to apoptosis via activation of ER stress-dependent autophagy
por: Cui, Jie, et al.
Publicado: (2020)

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021)

Bufei Decoction Alleviated Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Mice by Anti-Inflammation
por: Yang, Shanjun, et al.
Publicado: (2020)

ZNF768 links oncogenic RAS to cellular senescence
por: Villot, Romain, et al.
Publicado: (2021)

Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022)

Function and Transcriptional Regulation of Bovine TORC2 Gene in Adipocytes: Roles of C/EBPγ, XBP1, INSM1 and ZNF263
por: Khan, Rajwali, et al.
Publicado: (2019)

Pharmacological effects of Bufei Jianpi granule on chronic obstructive pulmonary disease and its metabolism in rats
por: Yang, Xin-Xin, et al.
Publicado: (2022)

ZNF768: controlling cellular senescence and proliferation with ten fingers
por: Villot, Romain, et al.
Publicado: (2021)

Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway
por: Mo, Yenan, et al.
Publicado: (2021)

Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis
por: Yang, Hao, et al.
Publicado: (2020)

High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis
por: Maique, Jenny, et al.
Publicado: (2020)

Health Tract, No. 263: Experimenting
Publicado: (1867)

Bufei Huoxue Capsule Attenuates PM2.5-Induced Pulmonary Inflammation in Mice
por: Jing, Yue, et al.
Publicado: (2017)

Lack of ZNF365 Drives Senescence and Exacerbates Experimental Lung Fibrosis
por: Urista, Juan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_67se10an156h7ktolscluiuue8